Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros

Base de dados
Tipo de documento
País de afiliação
Intervalo de ano de publicação
1.
J Eukaryot Microbiol ; 63(3): 299-308, 2016 05.
Artigo em Inglês | MEDLINE | ID: mdl-26496801

RESUMO

Trypanosoma cruzi is the etiological agent of Chagas disease. During its life cycle, it alternates among vertebrate and invertebrate hosts. Metabolic flexibility is a main biochemical characteristic of this parasite, which is able to obtain energy by oxidizing a variety of nutrients that can be transported from the extracellular medium. Moreover, several of these metabolites, more specifically amino acids, have a variety of functions beyond being sources of energy. Branched chain amino acids (BCAA), beyond their role in ATP production, are involved in sterol biosynthesis; for example, leucine is involved as a negative regulator of the parasite differentiation process occurring in the insect midgut. BCAA are essential metabolites in most nonphotosynthetic eukaryotes, including trypanosomes. In view of this, the metabolism of BCAA in T. cruzi depends mainly on their transport into the cell. In this work, we kinetically characterized the BCAA transport in T. cruzi epimastigotes. Our data point to BCAA as being transported by a single saturable transport system able to recognize leucine, isoleucine and valine. In view of this, we used leucine to further characterize this system. The transport increased linearly with temperature from 10 to 45 °C, allowing the calculation of an activation energy of 51.30 kJ/mol. Leucine uptake was an active process depending on ATP production and a H(+) gradient, but not on a Na(+) or K(+) gradient at the cytoplasmic membrane level.


Assuntos
Aminoácidos de Cadeia Ramificada/química , Aminoácidos de Cadeia Ramificada/metabolismo , Membrana Celular/metabolismo , Trypanosoma cruzi/metabolismo , Trifosfato de Adenosina/metabolismo , Sistemas de Transporte de Aminoácidos , Animais , Doença de Chagas/parasitologia , Isoleucina/metabolismo , Isoleucina/farmacologia , Cinética , Leucina/metabolismo , Leucina/farmacologia , Temperatura , Trypanosoma cruzi/efeitos dos fármacos , Valina/metabolismo , Valina/farmacologia
2.
Molecules ; 19(4): 5205-18, 2014 Apr 23.
Artigo em Inglês | MEDLINE | ID: mdl-24762961

RESUMO

The search of alternative compounds to control tropical diseases such as schistosomiasis has pointed to secondary metabolites derived from natural sources. Piper species are candidates in strategies to control the transmission of schistosomiasis due to their production of molluscicidal compounds. A new benzoic acid derivative and three flavokawains from Piper diospyrifolium, P. cumanense and P. gaudichaudianum displayed significant activities against Biomphalaria glabrata snails. Additionally, "in silico" studies were performed using docking assays and Molecular Interaction Fields to evaluate the physical-chemical differences among the compounds in order to characterize the observed activities of the test compounds against Biomphalaria glabrata snails.


Assuntos
Antiparasitários/química , Ácido Benzoico/química , Chalconas/química , Estágios do Ciclo de Vida/efeitos dos fármacos , Piper/química , Extratos Vegetais/química , Caramujos/efeitos dos fármacos , Animais , Antiparasitários/isolamento & purificação , Antiparasitários/farmacologia , Produtos Biológicos/química , Chalconas/isolamento & purificação , Chalconas/farmacologia , Reservatórios de Doenças , Humanos , Concentração Inibidora 50 , Simulação de Acoplamento Molecular , Extratos Vegetais/isolamento & purificação , Extratos Vegetais/farmacologia , Folhas de Planta/química , Schistosoma mansoni/fisiologia , Esquistossomose/prevenção & controle , Esquistossomose/transmissão , Caramujos/crescimento & desenvolvimento , Relação Estrutura-Atividade
3.
J Biomol Struct Dyn ; 35(6): 1244-1259, 2017 May.
Artigo em Inglês | MEDLINE | ID: mdl-27064715

RESUMO

A series of semicarbazone, thiosemicarbazone, and aminoguanidine derivatives were synthesized and tested as antitrypanosomal agents. The theoretical NMR of the compounds was calculated using molecular modeling techniques (density functional theory (DFT) calculations) and confirmed the formation of the compounds. The ability to inhibit cruzain and Trypanosoma cruzi epimastigote replication was evaluated. Cruzain inhibition ranged between 70 and 75% (100 µM), and IC50 values observed in epimastigote forms of T. cruzi ranged from 20 to 140 µM. Furthermore, the compounds did not present cytotoxicity at concentrations up to 50 and 250 µM in MTT tests. Molecular modeling studies were conducted using DFT method (B3LYP functional and the basis set 6-311G(d,p)) to understand the activity of the compounds, corroborating the observed cruzain inhibitory activity. In docking studies, the obtained analogs showed good complementarity with cruzain active site. In addition, docking results are in accordance with the susceptibility of these analogs to nucleophilic attack of the catalytic Cys25. Taken together, this study shows that this class of compounds can be used as a prototype in the identification of new antichagasic drugs.


Assuntos
Cisteína Endopeptidases/química , Desenho de Fármacos , Proteínas de Protozoários/química , Semicarbazonas/química , Tripanossomicidas/química , Animais , Sítios de Ligação , Células CHO , Domínio Catalítico , Sobrevivência Celular/efeitos dos fármacos , Cricetulus , Isomerismo , Espectroscopia de Ressonância Magnética , Conformação Molecular , Simulação de Acoplamento Molecular , Simulação de Dinâmica Molecular , Estrutura Molecular , Ligação Proteica , Proteínas de Protozoários/antagonistas & inibidores , Semicarbazonas/farmacologia , Tripanossomicidas/farmacologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA